Bryan Corporation

Focus: Bryan Corporation is a biotechnology company headquartered in Cincinnati, OH, specializing in airway dilation systems and a diverse clinical pipeline spanning oncology, cardiovascular, metabolic, immunology, and neurology indications.

Oncology Cardiovascular Metabolic Diseases Immunology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Bryan Corporation

AI assessmentNot Hiring

No open roles listed right now. Follow Bryan Corporation to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Mid-stage

2 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Precision Rehabilitation for Veterans With (HFpEF)

Heart Failure

N/A

Clinical Trials (1)

NCT07493915Precision Rehabilitation for Veterans With (HFpEF)

N/A

Help build intelligence for Bryan Corporation

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Broad therapeutic area coverage with 30 active pipeline programs spanning five major disease categories signals diverse clinical and commercial opportunities
Phase 3 programs in cardiovascular (Adenosine for heart transplant, Cryoprecipitate for trauma) offer near-term regulatory catalysts and potential rapid value creation
Early-stage biotech model allows hands-on involvement in drug development from Phase 1 through commercialization without large organizational bureaucracy

Watch Out For

No active job openings and missing employee count raise concerns about company size, stability, and immediate hiring capacity
Highly fragmented pipeline (30 programs with many non-traditional modalities like dietary interventions and psychological training) suggests unfocused strategy and limited commercial viability
Absence of published financials, revenue data, and patent cliff analysis indicates either pre-revenue status or opacity that obscures true financial health

Generated by Claude from Bryan Corporation's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Biomarker

Lung Cancer

N/A

Cognitive stress tests during functional MRI

Alzheimer Disease

N/A

Massage

Breast Cancer

N/A

Clinical Trials (1)

NCT03557554Investigating the Preventative Ability of Massage Therapy on Paclitaxel Induced Peripheral Neuropathy

N/A